Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Citi Upgrades Integra LifeSciences (IART) to Neutral
April 3, 2024 5:41 AM EDTCiti analyst Joanne Wuensch upgraded Integra LifeSciences (NASDAQ: IART) from Sell to Neutral with a price target of $38.00.
The analyst comments "Ongoing supply challenges and Boston remediation weigh down expectations, but likely in the stock: upgrading to Neutral from Sell Shares of IART have underperformed YTD, declining 20.3%... More
